Skip to Content

Patiromer Pregnancy and Breastfeeding Warnings

Patiromer is also known as: Veltassa

Medically reviewed on Mar 31, 2017

Patiromer Pregnancy Warnings

In animal studies, this drug did not impair fertility in males or females at doses up to 10-fold the maximum recommended human dose (MRHD).

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

Use is considered acceptable.

US FDA pregnancy category: Not assigned

Comment:
-This drug is not absorbed systemically following oral administration and maternal use is not expected to result in fetal risk.

See references

Patiromer Breastfeeding Warnings

Use is considered acceptable.

Excreted into human milk: No

Comment:
-This drug is not absorbed systemically following oral administration and maternal use is not expected to result in infant risk.

See references

References for pregnancy information

  1. "Product Information. Veltassa (patiromer)." Relypsa, Inc., Redwood City, CA.

References for breastfeeding information

  1. "Product Information. Veltassa (patiromer)." Relypsa, Inc., Redwood City, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide